Navigation Links
Guardant Health Announces Milestone Partnership with Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Date:11/16/2016

REDWOOD CITY, Calif. and CHICAGO, Nov. 16, 2016 /PRNewswire/ -- Guardant Health Inc. announced today a comprehensive partnership with Northwestern University that will make Guardant360 the preferred liquid biopsy test for patients with advanced cancer treated at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. The agreement also covers multiple large-scale prospective clinical trials that will apply Guardant Health's technology to a variety of indications across the cancer-care continuum.

"As the Lurie Cancer Center OncoSET (Sequence, Evaluate, Treat) Program develops into an international leader in precision medicine, establishing a partnership for a liquid biopsy test was important," said Leonidas Platanias, MD, PhD, director of the Lurie Cancer Center. "Our program will benefit from Guardant Health's non-invasive technology. At the same time, we will promote and advance our precision oncology research by conducting large-scale prospective studies."

Together, Guardant Health and the Lurie Cancer Center will track the outcomes of patients with advanced cancer whose treatment selection was guided by Guardant360. In addition, every patient evaluated within the Lurie Cancer Center OncoSET Program will be enrolled in one of several prospective clinical trials exploring additional clinical uses of liquid biopsy.

Guardant360, the first comprehensive liquid biopsy, was introduced in 2014. It has been used by more than 2,500 oncologists to identify somatic genomic alterations associated with targeted therapies in the tumor DNA of more than 20,000 patients with advanced cancer. 

"The future of cancer diagnostics lies in minimally-invasive sampling methods and sophisticated, sensitive testing. With Guardant Health's liquid biopsy, we can access our patients' comprehensive genomic information with minimal risk," said Massimo Cristofanilli, MD, Associate Director for Translational Research and Precision Medicine at the Lurie Cancer Center, and Director of the OncoSET Program. "This collaboration will help us determine the value of prospective molecular monitoring in patients with advanced disease by exploring the potential of liquid biopsy specifically, and precision oncology in general, to impact lives."

"We are excited to partner with Northwestern, one of the world's leading cancer centers," said Helmy Eltoukhy, PhD, Guardant Health's co-founder and CEO. "Lurie Cancer Center clinicians have already used our technology to guide treatment for hundreds of patients, and this agreement speaks to the utility of our technology. It demonstrates a real desire among oncologists and their patients for a 'blood-first' liquid biopsy approach to advanced cancer genotyping."

About Lurie Cancer Center

The Robert H. Lurie Comprehensive Cancer Center of Northwestern University, one of only 47 National Cancer Institute-designated Comprehensive Cancer Centers in the country, is committed to being a national leader in the battle to overcome cancer. To this end, the Lurie Cancer Center is dedicated to scientific discovery, advancing medical knowledge, providing compassionate, state-of-the-art cancer care, and training the next generation of clinicians and scientists.  For more information, visit cancer.northwestern.edu.

About Guardant Health

Guardant Health, headquartered in Redwood City, Calif., is focused on developing breakthrough diagnostics that can transform cancer into a manageable disease. Guardant Health was founded in 2012 by a team of entrepreneurs with expertise in next-generation sequencing, single-cell genomics, and cancer diagnostics. The company has raised more than $200 million from leading venture capital firms. Its first product, Guardant360, came to market in 2014, and is now the most validated and sensitive comprehensive liquid biopsy commercially available.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/guardant-health-announces-milestone-partnership-with-robert-h-lurie-comprehensive-cancer-center-of-northwestern-university-300363932.html


'/>"/>
SOURCE Guardant Health
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Guardant Health to Present at the WedBush 2014 Life Sciences Management Access Conference
2. Guardant Health Presents Data on Biopsy-Free Tumor Genomic Profiling Of More Than 2000 Clinical Samples via Guardant360
3. Guardant Health Appoints Mort Minaee, Former Roche Senior Director, as VP of Regulatory Affairs
4. Van Dyk Invests In Key Resources To Prepare For Healthcare Reform
5. Cumberland Pharmaceuticals To Present At The UBS Global Healthcare Conference In New York
6. North America Home Healthcare Market Worth $130.4 Billion by 2017
7. Pentec Health Announces Limited Voluntary Recall of Certain Compounded Prescription Therapies for Renal Patients
8. Physician-Patient Alliance for Health & Safety Announces Four Essentials for Safety for Patients Receiving Opioids
9. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
10. Wireless Pill Bottle Wins Healthcare Innovation World Cup
11. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2019)... ... June 19, 2019 , ... One is never too old to make dreams ... Home (LAJH). Known as a destination for Los Angeles-area seniors, LAJH has an environment ... and Mildred Moccio, it is also a point of embarkation: a place from which ...
(Date:6/19/2019)... ... June 19, 2019 , ... A new survey by The ... $376 per month on healthcare costs. If that doesn’t sound like enough of ... per month, one-in-five survey participants reported spending $1,000 per month or more. The ...
(Date:6/18/2019)... , ... June 18, 2019 , ... ... emergency medicine and hospital medicine management services, are pleased to announce the acquisition ... in Longview, Texas. , LEMA’s 34 physicians and 9 advanced practice clinicians ...
Breaking Medicine Technology:
(Date:6/24/2019)... ... 2019 , ... Cibo Vita, Inc., makers of Nature’s Garden, NutriPops, Chocolate Orchard ... indulgence snack line at the 65th annual Summer Fancy Food Show, taking place at ... booth #5721. , The company’s expansive product portfolio features a variety of trail ...
(Date:6/20/2019)... ... , ... Access Healthcare, one of the largest providers of ... appointed as Senior Vice President of Client Services. Angel brings more than 20 ... high performing teams, and driving revenue growth for healthcare companies. , In this ...
(Date:6/19/2019)... (PRWEB) , ... June 19, ... ... from non-governmental organizations, academia, faith-based organizations, private institutions, media, and government joined ... DC to make commitments to improve universal access to water, sanitation, and ...
(Date:6/19/2019)... , ... June 19, 2019 , ... A legal-medical ... the United States, has filed class action lawsuits in 34 of the 48 ... in the class actions are an array of pharmaceutical manufacturers, distributors and retailers, all ...
(Date:6/19/2019)... ... June 19, 2019 , ... Ovation® Fertility scientists have been invited ... Reproduction and Embryology (ESHRE) Annual Meeting in Vienna, June 23-26, 2019. , Ovation’s ... consideration for both the Basic Science Award for Oral Presentation and the Fertility Society ...
Breaking Medicine News(10 mins):